Note 9 – Supplemental Information to the Condensed Consolidated Financial Statements

The following table summarizes the change in the accounts receivable allowance for credit losses for the periods presented (in thousands):


	Three Months Ended March 31,
	2026			2025
Accounts receivable allowance for credit losses, beginning of period	$	1,079		$	1,169
Write-offs		314			(319	)
Expense		(109	)		456
Accounts receivable allowance for credit losses, end of period	$	1,284		$	1,306

The following table provides information about accounts receivable and deferred revenues from contracts with customers (in thousands):


	As of March 31,		As of December 31,
	2026		2025
Accounts receivable, net	$	146,068	$	100,465
Deferred revenue	$	16,732	$	7,376

The Company does not disclose the aggregate transaction price for remaining performance obligations, generally because either the revenue from the satisfaction of the performance obligations is recognized in the amount invoiced or the original expected duration of the contract is one year or less.

Contract liabilities represent consideration received or consideration which is unconditionally due from customers prior to transferring goods or services to the customer under the terms of the contract and is included within deferred revenue in the accompanying consolidated balance sheets.

The following table presents a reconciliation of contract liabilities for the periods presented (in thousands):


	Three Months Ended March 31,
	2026			2025
Deferred revenue, beginning of period	$	7,376		$	8,002
Deposits received		13,433			7,735
Revenue recognized		(4,077	)		(8,159	)
Deferred revenue, end of period	$	16,732		$	7,578

Accrued liabilities as of March 31, 2026 and December 31, 2025 consisted of the following (in thousands):


	As of March 31,		As of December 31,
	2026		2025
Accrued payroll and employee expenses	$	20,501	$	20,167
Accrued taxes		6,295		1,916
Customer deposits		2,905		480
Accrued interest		272		1,598
Accrued transaction costs		140		—
Other accrued liabilities		1,545		2,748
Total accrued expenses	$	31,658	$	26,909


	Three Months Ended March 31,
	2026		2025
Supplemental disclosures of investing and financing activities
Cash paid for interest	$	3,040	$	4,274
Cash paid for income taxes	$	—	$	—
Supplemental schedule of non-cash activities
Lease liabilities arising from obtaining operating right-of-use assets	$	1,372	$	345
Lease liabilities arising from obtaining financing right-of-use assets	$	2,668	$	3,803